FIELD: osteoplastics. SUBSTANCE: method of treating human or animal bone tissue is distinguished by preserving non- denatured I-type collagen in intact state contained in original mineral bone structure and performing at least one selective extraction and/or denaturation of non-collagen structure proteins, the latter operation being performed involving urea-based selective extraction. EFFECT: improved quality of prepared material. 12 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR BONE TISSUE BIOMATERIAL OBTAINING, AND MATERIAL FOR OSTEOPLASTY AND TISSUE ENGINEERING OBTAINED BY SUCH METHOD | 2005 |
|
RU2342162C1 |
| METHOD FOR OBTAINING MATERIAL FOR BIOPLASTIC OPERATIONS AND MATERIAL FOR BIOPLASTIC OPERATIONS | 2017 |
|
RU2663283C1 |
| MATERIAL FOR OSTEOPLASTY AND METHOD FOR PRODUCTION THEREOF | 2005 |
|
RU2278679C1 |
| METHOD FOR OBTAINING OSTEOPLASTIC MATERIAL | 2015 |
|
RU2609201C1 |
| BIO-COMPOSITION MATERIAL APPLIED FOR OSTEOPLASTY | 2006 |
|
RU2325170C1 |
| METHOD FOR BIOLOGICALLY ACTIVE IMPLANTS OBTAINING | 2016 |
|
RU2619870C1 |
| METHOD FOR PRODUCTION OF BIOCOMPATIBLE DENTAL MATERIAL | 2005 |
|
RU2278655C1 |
| METHOD FOR PRODUCING OSTEOPLASTIC BIOMATERIALS FROM BONE TISSUE | 2019 |
|
RU2721604C1 |
| METHOD FOR OBTAINING COLLAGEN FROM BONE TISSUE | 2004 |
|
RU2273489C1 |
| BIORESORABLE BIOLOGICAL MATRIX FOR SUBSTITUTION OF BONE TISSUE DEFECTS AND METHOD OF ITS OBTAINING | 2017 |
|
RU2665962C1 |
